menu
    • menu

    Company profile for Genelux

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genelux is leading the way in understanding and translating the science behind oncolytic viruses. We have developed a robust drug discovery capability, and are building a pipeline of innovative oncolytic virus-based cancer therapies and collaborates with leading medical and academic research institutions, clinicians and scientists to replicate, validate, and maximize the potential applications and impact of its discoveries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GeneluxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3030 Bunker Hill Street San Diego, CA 92109 United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genelux.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genelux Corp. Unveils 2025 Financials, Business Updates
    Genelux Corp. Unveils 2025 Financials, Business Updates

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259445/0/en/Genelux-Corporation-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Genelux Corporation To Participate In Upcoming Conferences
    Genelux Corporation To Participate In Upcoming Conferences

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240144/0/en/Genelux-Corporation-to-Participate-in-Upcoming-Conferences.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Genelux Corp. To Host Virtual Fireside Chat With Titan Partners
    Genelux Corp. To Host Virtual Fireside Chat With Titan Partners

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217338/0/en/Genelux-Corporation-Announces-Upcoming-Virtual-Fireside-Chat-Hosted-by-Titan-Partners.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Genelux Sets $20M Public Stock Offering Price
    Genelux Sets $20M Public Stock Offering Price

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215457/0/en/Genelux-Corporation-Announces-Pricing-of-20-0-Million-Underwritten-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Genelux Corporation Announces Proposed Stock Offering
    Genelux Corporation Announces Proposed Stock Offering

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214887/0/en/Genelux-Corporation-Announces-Proposed-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Genelux Shows Positive Interim Olvi-Vec Data In Lung Cancer
    Genelux Shows Positive Interim Olvi-Vec Data In Lung Cancer

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212691/0/en/Genelux-Corporation-Reports-Encouraging-Interim-Data-of-Systemic-Administration-of-Olvi-Vec-in-Ongoing-Lung-Cancer-Trials.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search